Role of biotechnology and life sciences in UAE’s healthcare ambitions – Gulf Business
Globally, the UAE ranked twentieth in the 2021 World Index of Healthcare Innovation. This is a strong showing for the country and not at all unexpected when we consider the proactive steps taken...
Terasaki Innovation Summit to focus on improving technological, entrepreneurial translation of personalized medicines
The Terasaki Institute for Biomedical Innovation (TIBI) will be hosting the Terasaki Innovation Summit on March 8-10, 2023, at the UCLA Meyer & Renee Luskin Center in Los Angeles. This inaugural event will focus...
Cold Spring Harbor Laboratory receives new funding for free biomedical research platforms
COLD SPRING HARBOR, NY — Cold Spring Harbor Laboratory (CSHL) announced today that the preprint servers bioRxiv and medRxiv have received renewed funding from the Chan Zuckerberg Initiative (CZI). CZI has supported bioRxiv since...
Cancer Cells’ Ability to Escape Immunity is Pre-Existing, DNA Barcoding Study Says
Immunoediting (the process by which cancer cells evade the immune system) results when cancer cells that are more immunogenic are selectively eliminated, resulting in a population of less-immunogenic cancer cells that are able to...
UC San Diego Health awarded advanced certification in spine surgery
UC San Diego Health has earned The Joint Commission’s Gold Seal of Approval for Advanced Certification in Spine Surgery (ACSS) by meeting or exceeding the highest level of national performance standards. The Gold Seal...
EdiGene Biotechnology Moves into New R&D Center at Waltham, Mass. to Advance Proprietary LEAPER™...
BEIJING & WALTHAM, Mass., November 07, 2022--(BUSINESS WIRE)--EdiGene, Inc., a global, clinical-stage company focused on translating its gene-editing technologies into transformative genetic medicines for patients with significant unmet medical needs, announced its subsidiary, EdiGene...
Beyond vaccines: emerging technologies capable of unlocking the promise of biologically targeted mRNA therapeutics
In a recent article published in Nature Biotechnology, researchers reviewed technology advancements that will unlock the promise of biologically targeted messenger ribonucleic acid (mRNA) therapeutics beyond vaccines.
Study: Unlocking the promise of mRNA therapeutics....
C16 Biosciences Gears up to Go Palmless
The NYC-based synthetic biology company, C16 Biosciences, is developing novel ways to produce next-generation oils and fats. Recently, the company announced the successful completion of its first industrial-scale, 50,000 L, fermentation. In addition, the...
Panelists Discuss Ethics of Biotechnology at Science, Technology, and Society Symposium | News –...
Medical and legal authorities spoke about the ethics and future of biotechnology at a Friday panel hosted by the Program on Science, Technology, and Society at the Harvard Kennedy School.As part of the 20th...
Vir Biotechnology Presents New Data Evaluating the Potential for VIR-2218 and VIR-3434 to Achieve...
– Data from multiple ongoing trials evaluating Vir’s two novel HBV therapies continue to demonstrate substantial reductions in hepatitis B surface antigen (HBsAg) with no new safety signals – – Preliminary data to-date show...
